UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA. (17th June 2021) - Pulsoni, A.; Tosti, M. E.; Ferrero, S.; Luminari, S.; Dondi, A.; Liberati, A. M.; Cenfra, N.; Renzi, D.; Zanni, M.; Boccomini, C.; Ferreri, A. J.; Rattotti, S.; et al.